Aurora Cannabis Partners with Leafio to Improve Medical Cannabis Access in Australia

Aurora Cannabis Partners with Leafio to Enhance Medical Cannabis Access in Australia

Aurora Cannabis Inc., a key player in the global medical cannabis sector, announces a strategic distribution partnership between its subsidiary, MedReleaf Australia, and Leafio, the wholesale distribution arm of Montu Australia. This collaboration aims to significantly improve access to safe and reliable medical cannabis for Australian patients while equipping healthcare professionals with essential educational resources. Leafio is set to distribute Aurora's diverse range of medical cannabis products, which includes well-known brands such as MedReleaf, CraftPlant, Aurora, Whistler Cannabis Co., and IndiMed. The partnership leverages Leafio's extensive nationwide supply chain, which connects over 4,000 pharmacies across Australia.

Stanley Sack, the Interim Managing Director of MedReleaf Australia, emphasizes the excitement surrounding the partnership, noting the strong alignment between Aurora's Therapeutic Goods Administration (TGA) and Good Manufacturing Practice (GMP) certified products and Leafio's comprehensive clinician education expertise. This synergy is expected to not only enhance product availability but also facilitate better understanding and usage of medical cannabis among healthcare providers. The collaboration underscores Aurora's commitment to improving patient outcomes through increased accessibility and education, which are critical components in the evolving landscape of medical cannabis in Australia.

Nicole Le Maistre, General Manager of Leafio, highlights the partnership's potential to foster research, product innovation, and ultimately improve patient outcomes. By combining Aurora's high-quality medical cannabis offerings with Leafio's distribution capabilities, the alliance seeks to create a more informed healthcare community and a better experience for patients seeking relief through medical cannabis. This development marks a significant step in Aurora's efforts to expand its footprint in the Australian market, aligning with its broader mission to advance the global cannabis industry through scientific research and innovation.

In addition to this partnership, Aurora Cannabis continues to maintain a robust portfolio that includes both medical and consumer markets across Canada, Europe, Australia, and New Zealand. The company is dedicated to driving advancements in the cannabis industry while also holding a controlling interest in Bevo Farms Ltd., a leading supplier of propagated agricultural plants in North America. This multifaceted approach not only strengthens Aurora's market position but also supports its ongoing commitment to quality and innovation in the cannabis industry.

As Aurora Cannabis forges ahead with this new partnership, it sets a precedent for future collaborations aimed at expanding access to medical cannabis and enhancing the overall framework for healthcare providers and patients in Australia.